Donatus U Ekwueme1, Gery P Guy2, Sun Hee Rim2, Arica White2, Ingrid J Hall2, Temeika L Fairley2, Hazel D Dean3. 1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia. Electronic address: dce3@cdc.gov. 2. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, Georgia. 3. Office of the Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease and Control Prevention, Atlanta, Georgia.
Abstract
BACKGROUND: Breast cancer is the second-leading cause of cancer-related deaths among women aged <50 years. Studies on the effects of breast cancer mortality among young women are limited. PURPOSE: To assess trends in breast cancer mortality rates among women aged 20-49 years, estimate years of potential life lost (YPLL), and the value of productivity losses due to premature mortality. METHODS: Age-adjusted rates and rate ratios (RRs) were calculated using 1970-2008 U.S. mortality data. Breast cancer mortality rates over time were assessed using Joinpoint regression modeling. YPLL was calculated using number of cancer deaths and the remaining life expectancy at the age of death. Value of productivity losses was estimated using the number of deaths and the present value of future lifetime earnings. RESULTS: From 1970 to 2008, the age-adjusted breast cancer mortality rate among young women was 12.02/100,000. Rates were higher in the Northeast (RR=1.03, 95% CI, 1.02-1.04). The annual decline in breast cancer mortality rates among blacks was smaller (-0.68%) compared with whites (-2.02%). The total number of deaths associated with breast cancer was 225,866, which accounted for an estimated 7.98 million YPLL. The estimated total productivity loss in 2008 was $5.49 billion and individual lifetime lost earnings were $1.10 million. CONCLUSIONS: Considering the effect of breast cancer on women of working age and the disproportionate impact on black women, more age-appropriate interventions with multiple strategies are needed to help reduce these substantial health and economic burdens, improve survival, and in turn reduce productivity costs associated with premature death. Published by American Journal of Preventive Medicine on behalf of American Journal of Preventive Medicine.
BACKGROUND:Breast cancer is the second-leading cause of cancer-related deaths among women aged <50 years. Studies on the effects of breast cancer mortality among young women are limited. PURPOSE: To assess trends in breast cancer mortality rates among women aged 20-49 years, estimate years of potential life lost (YPLL), and the value of productivity losses due to premature mortality. METHODS: Age-adjusted rates and rate ratios (RRs) were calculated using 1970-2008 U.S. mortality data. Breast cancer mortality rates over time were assessed using Joinpoint regression modeling. YPLL was calculated using number of cancer deaths and the remaining life expectancy at the age of death. Value of productivity losses was estimated using the number of deaths and the present value of future lifetime earnings. RESULTS: From 1970 to 2008, the age-adjusted breast cancer mortality rate among young women was 12.02/100,000. Rates were higher in the Northeast (RR=1.03, 95% CI, 1.02-1.04). The annual decline in breast cancer mortality rates among blacks was smaller (-0.68%) compared with whites (-2.02%). The total number of deaths associated with breast cancer was 225,866, which accounted for an estimated 7.98 million YPLL. The estimated total productivity loss in 2008 was $5.49 billion and individual lifetime lost earnings were $1.10 million. CONCLUSIONS: Considering the effect of breast cancer on women of working age and the disproportionate impact on black women, more age-appropriate interventions with multiple strategies are needed to help reduce these substantial health and economic burdens, improve survival, and in turn reduce productivity costs associated with premature death. Published by American Journal of Preventive Medicine on behalf of American Journal of Preventive Medicine.
Authors: M Colleoni; N Rotmensz; C Robertson; L Orlando; G Viale; G Renne; A Luini; P Veronesi; M Intra; R Orecchia; G Catalano; V Galimberti; F Nolé; G Martinelli; A Goldhirsch Journal: Ann Oncol Date: 2002-02 Impact factor: 32.976
Authors: Phyllis A Wingo; Cheryll J Cardinez; Sarah H Landis; Robert T Greenlee; Lynn A G Ries; Robert N Anderson; Michael J Thun Journal: Cancer Date: 2003-06-15 Impact factor: 6.860
Authors: Kee Seng Chia; Wen Bo Du; R Sankaranarayanan; Risto Sankila; Hao Wang; Jeannette Lee; Adeline Seow; Hin Peng Lee Journal: Int J Cancer Date: 2004-02-20 Impact factor: 7.396
Authors: Benjamin T Allaire; Donatus U Ekwueme; Gery P Guy; Chunyu Li; Florence K Tangka; Katrina F Trivers; Susan A Sabatino; Juan L Rodriguez; Justin G Trogdon Journal: Am J Prev Med Date: 2016-02 Impact factor: 5.043
Authors: Justin G Trogdon; Xuejun Liu; Katherine E Reeder-Hayes; Jason Rotter; Donatus U Ekwueme; Stephanie B Wheeler Journal: Cancer Date: 2020-07-10 Impact factor: 6.921
Authors: Layal Chaker; Abby Falla; Sven J van der Lee; Taulant Muka; David Imo; Loes Jaspers; Veronica Colpani; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2015-04-03 Impact factor: 8.082
Authors: Donatus U Ekwueme; Benjamin T Allaire; William J Parish; Cheryll C Thomas; Diana Poehler; Gery P Guy; Arnie P Aldridge; Sejal R Lahoti; Temeika L Fairley; Justin G Trogdon Journal: Am J Prev Med Date: 2017-09 Impact factor: 5.043
Authors: Abdul K Siraj; Shaham Beg; Zeenath Jehan; Sarita Prabhakaran; Maqbool Ahmed; Azhar R Hussain; Fouad Al-Dayel; Asma Tulbah; Dahish Ajarim; Khawla S Al-Kuraya Journal: Breast Cancer Res Date: 2015-09-17 Impact factor: 6.466